FGF13 antibody
Principal name
FGF13 antibody
Alternative names for FGF13 antibody
Fibroblast growth factor 13, FGF-13, FHF2, Fibroblast growth factor homologous factor 2
Ncbi ID
9606, NP_004105, NP_001132970.1, NM_033642, NP_378668, 10090, NM_010200, NM_001139498, NM_001139500, NM_001139501, NM_001139502
Available reactivities
Available hosts
Available applications
Enzyme Immunoassay (E), ELISA (detection) (E(detection)), Western blot / Immunoblot (WB), Paraffin Sections (P), Immunocytochemistry/Immunofluorescence (ICC/IF), Immunoprecipitation (IP), Frozen Sections (C)
Background of FGF13 antibody
FGF13 (Fibroblast growth factor 13), also called FHF2 is a protein that in humans is encoded by the FGF13 gene.The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF13is a large gene, extending over approximately 200 kb in Xq26.3, and contains at least 7 exons. By cytogenetic, FISH, and database analysis, Gecz et al. (1999) localized the FGF13 gene within a 400-kb duplication interval on chromosome Xq26.3. FGF family members possess broad mitogenic and cell survival activities, and are involved in a variety of biological processes, including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth, and invasion.
This gene is located to a region associated with Borjeson-Forssman-Lehmann syndrome (BFLS), a syndromal X-linked mental retardation, which suggests it may be a candidate gene for familial cases of the BFL syndrome. The function of this gene has not yet been determined. Two alternatively spliced transcripts encoding different isoforms have been described for this gene.
General readings
Popovici,C., (2004) J. Biol. Chem. 279 (38), 40146-40152
Western Blot analysis of FGF13 expression in transfected 293T cell line (H00002258-T01) by FGF13 MaxPab polyclonal antibody.Lane 1: FGF13 transfected lysate(26.95 KDa).Lane 2: Non-transfected lysate.
Western Blot analysis of FGF13 expression in transfected 293T cell line (H00002258-T01) by FGF13 MaxPab polyclonal antibody.Lane 1: FGF13 transfected lysate(27.60 KDa).Lane 2: Non-transfected lysate.
Human 293T; WB Suggested Anti-FGF13 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:62500. Positive Control: 293T cell lysate. FGF13 is supported by BioGPS gene expression data to be expressed in HEK293T.; FGF13 antibody - middle region (ARP55412_P050) in Human 293T cells using Western Blot
Human 293T; Host:Rabbit. Target Name:FGF13. Sample Tissue:Human 293T. Antibody Dilution: 1.0ug/ml. FGF13 is supported by BioGPS gene expression data to be expressed in HEK293T.; FGF13 antibody - middle region (ARP55413_P050) in Human 293T cells using Western Blot
Human Hela; Host:Rabbit. Target Name:FGF13. Sample Tissue:Human Hela. Antibody Dilution: 1.0ug/ml. FGF13 is supported by BioGPS gene expression data to be expressed in HeLa.; FGF13 antibody - middle region (ARP55413_P050) in Human Hela cells using Western Blot
Human Jurkat; WB Suggested Anti-FGF13 Antibody Titration: 0.2-1 ug/ml. ELISA Titer: 1:1562500. Positive Control: Jurkat cell lysate; FGF13 antibody - middle region (ARP55413_P050) in Human Jurkat cells using Western Blot
Immunohistochemical staining of paraffin-embedded Carcinoma of Human kidney tissue using anti-FGF13 mouse monoclonal antibody.(Heat-induced epitope retrieval by 1mM EDTA in 10mM Tris buffer (pH8.5) at 120 oC for 3 min, TA807761)(1:150)
Immunohistochemical staining of paraffin-embedded Adenocarcinoma of Human ovary tissue using anti-FGF13 mouse monoclonal antibody.(Heat-induced epitope retrieval by 1mM EDTA in 10mM Tris buffer (pH8.5) at 120 oC for 3 min, TA807761)(1:150)
Immunohistochemical staining of paraffin-embedded Adenocarcinoma of Human endometrium tissue using anti-FGF13 mouse monoclonal antibody.(Heat-induced epitope retrieval by 1mM EDTA in 10mM Tris buffer (pH8.5) at 120 oC for 3 min, TA807761)(1:150)
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FGF13 (RC204164, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FGF13.(1:2000)
HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY FGF13 (RC204164, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-FGF13.(1:2000)
Transfected cell immunoblot: extracts of whole rat brain homogenate (WBH) and COS cells transfected with GFP-tagged FGF11/FHF3 and FGF13/FHF2 and untagged Kv2.1 plasmids and probed with N91/27 (left) and N52A/42 (right) TC supe.
Transfected cell immunoblot: extracts of whole rat brain homogenate (WBH) and COS cells transfected with GFP-tagged FGF11/FHF3 and FGF13/FHF2 and untagged Kv2.1 plasmids and probed with N91/27 (left) and N52A/42 (right) TC supe.
Transfected cell immunoblot: extracts of COS cells transiently transfected with GFP-tagged FGF13B/FHF2B, FGF13A/FHF2A or untagged Kv2.1 plasmid and probed with N225A/10 (left) or N86/8 (right) TC supe.
Transfected cell immunoblot: extracts of COS cells transiently transfected with GFP-tagged FGF13B/FHF2B, FGF13A/FHF2A or untagged Kv2.1 plasmid and probed with N225A/10 (left) or N86/8 (right) TC supe.
Adult rat brain membrane immunoblot
Adult rat hippocampus immunohistochemistry
Adult rat brain membrane immunoblot
Adult rat hippocampus immunohistochemistry
(0.5ug/ml) staining of Mouse Brain lysate (35ug protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.
Western blot analysis of extracts from Jurkat cells and HepG2 cells, using FGF13 antibody.The lane on the right is treated with the synthesized peptide.
WB Suggested Anti-FGF13 Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1: 1562500; Positive Control: Jurkat cell lysate
Host: Rabbit; Target Name: FGF13; Sample Tissue: Human Hela; Antibody Dilution: 1.0 ug/mlFGF13 is supported by BioGPS gene expression data to be expressed in HeLa
Host: Rabbit; Target Name: FGF13; Sample Tissue: Human 293T; Antibody Dilution: 1.0 ug/mlFGF13 is supported by BioGPS gene expression data to be expressed in HEK293T
WB Suggested Anti-FGF13 Antibody Titration: 0.2-1 ug/ml; ELISA Titer: 1: 62500; Positive Control: 293T cell lysateFGF13 is supported by BioGPS gene expression data to be expressed in HEK293T
- Quick-Filters:
- Highly Validated (1)
Primary Antibodies
| Catalog No. | Host | Iso. | Clone | Pres. | React. | Applications | |
|---|---|---|---|---|---|---|---|
| TA807761 | FGF13 antibody |
||||||
| FGF13 mouse monoclonal antibody, clone OTI7E8 (formerly 7E8) | |||||||
 |
Mouse | IgG1 | OTI7E8 | Purified | Hu | P, WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
 +3 additional images |
Highly validated antibody!
|
||||||
| TA311284 | FGF13 antibody |
||||||
| Goat Anti-FGF13 (isoform 1) Antibody | |||||||
 |
Goat | Purified | Bov, Can, Ms, Por | WB |
0.1 mg /
€360.00
|
||
| OriGene Technologies, Inc. | |||||||
| TA313871 | FGF13 antibody |
||||||
| Rabbit polyclonal anti-FGF13 antibody | |||||||
 |
Rabbit | IgG | Purified | Hu, Ms | E, WB |
0.1 ml /
€335.00
|
|
| OriGene Technologies, Inc. | |||||||
| TA807774 | FGF13 antibody |
||||||
| FGF13 mouse monoclonal antibody, clone OTI1D5 (formerly 1D5) | |||||||
 |
Mouse | IgG1 | OTI1D5 | Purified | Hu | WB |
0.1 ml /
€360.00
|
| OriGene Technologies, Inc. | |||||||
|
|||||||
| 73-134 | FGF13 antibody |
||||||
 |
Mouse | IgG1 | N91/27 | Supernatant | Hu, Ms, Rt | ICC/IF, IP, WB |
5 ml /
€490.00
|
| Antibodies Incorporated | |||||||
|
|||||||
| 73-248 | FGF13 (B Isoform) antibody |
||||||
 |
Mouse | IgG2a | N225A/10 | Supernatant | Hu, Ms, Rt | C, ICC/IF, WB |
5 ml /
€490.00
|
| Antibodies Incorporated | |||||||
|
|||||||
| 75-134 | FGF13 antibody |
||||||
 |
Mouse | IgG1 | N91/27 | Purified | Hu, Ms, Rt | ICC/IF, IP, WB |
0.1 ml /
€570.00
|
| Antibodies Incorporated | |||||||
|
|||||||
| 75-248 | FGF13 (B Isoform) antibody |
||||||
 |
Mouse | IgG2a | N225A/10 | Purified | Hu, Ms, Rt | C, ICC/IF, WB |
0.1 ml /
€570.00
|
| Antibodies Incorporated | |||||||
|
|||||||
| AM60047PU-N | FGF13 pan (N-term) antibody |
||||||
 |
Mouse | IgG2b | S235-22 | Purified | Hu, Ms, Rt | ICC/IF, P, WB |
0.1 mg /
€410.00
|
| OriGene Technologies GmbH | |||||||
| 73-246 | Pan-FHF-A antibody |
||||||
 |
Mouse | IgG2b | N235/22 | Supernatant | Hu, Ms, Rt | C, ICC/IF, WB |
5 ml /
€490.00
|
| Antibodies Incorporated | |||||||
| +1 additional image |
|
||||||
| 75-246 | Pan-FHF-A antibody |
||||||
 |
Mouse | IgG2b | N235/22 | Purified | Hu, Ms, Rt | C, ICC/IF, WB |
0.1 ml /
€570.00
|
| Antibodies Incorporated | |||||||
| +1 additional image |
|
||||||
Proteins & Growth Factors
| Catalog No. | Species | Pres. | Purity | Source | |
|---|---|---|---|---|---|
| TP317121 | FGF13 (transcript variant 6) |
||||
| Purified recombinant protein of Homo sapiens fibroblast growth factor 13 (FGF13), transcript variant 6 | |||||
 |
Human | > 80 % Preparation: Recombint protein was captured through anti-DDK affinity column followed by conventiol chromatography steps. Purity Detail: > 80% as determined by SDS-PAGE and Coomassie blue staining. |
HEK293 cells |
20 µg /
€748.00
|
|
| OriGene Technologies, Inc. | |||||
Lysates
| Catalog No. | ||
|---|---|---|
| LY409478 | FGF13 overexpression lysate |
|
|
0.1 mg /
€295.00
|
|
| OriGene Technologies, Inc. | ||
| LY429884 | FGF13 overexpression lysate |
|
|
0.1 mg /
€315.00
|
|
| OriGene Technologies, Inc. |